These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 17605923

  • 1. [Clinical application of keratoprosthesis for corneal opacity caused by chemical burn unsuitable for keratoplasty].
    Huang YF, Wang DJ, Wang LQ, Zhang H, Ma X.
    Zhonghua Yan Ke Za Zhi; 2007 Apr; 43(4):297-302. PubMed ID: 17605923
    [Abstract] [Full Text] [Related]

  • 2. [Clinical application of keratoprosthesis for corneal opacity unsuitable for keratoplasty].
    Huang YF, Wang LQ, Wang FX.
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):578-81. PubMed ID: 14766069
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing.
    Huang Y, Yu J, Liu L, Du G, Song J, Guo H.
    Ophthalmology; 2011 Jan; 118(1):41-6. PubMed ID: 20813411
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ, Kamal KM, Vo RC, Yu F.
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M, Dohlman CH.
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [Abstract] [Full Text] [Related]

  • 11. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC, Hernandez EG, Schwab IR, Mannis MJ.
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [Abstract] [Full Text] [Related]

  • 12. Boston type 1 keratoprosthesis outcomes in ocular burns.
    Magalhães FP, Hirai FE, de Sousa LB, de Oliveira LA.
    Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
    [Abstract] [Full Text] [Related]

  • 13. International results with the Boston type I keratoprosthesis.
    Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, Kharashi SA, Jindan MA, Tandon R, Mascarenhas J, Malyugin B, Padilla MD, Maskati Q, Agarwala N, Hutauruk J, Sharma M, Yu F.
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [Abstract] [Full Text] [Related]

  • 14. [Outcome of combined penetrating keratoplasty with vitreoretinal surgery using temporary Eckardt keratoprosthesis].
    Levy J, Kratz A, Klemperer I, Lifshitz T.
    Harefuah; 2005 Nov; 144(11):781-4, 822. PubMed ID: 16358653
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
    Kim MK, Lee SM, Lee JL, Chung TY, Kim YH, Wee WR, Lee JH.
    Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study.
    Gu J, Zhai J, Zhou S, Chen J.
    Adv Ther; 2016 May; 33(5):760-73. PubMed ID: 27126407
    [Abstract] [Full Text] [Related]

  • 19. [Effect of lamellar keratoplasty time on the production of serum specific antibody in corneal alkali burns].
    Zheng XF, Feng KX, Li B, Yang JZ, Ge JJ.
    Zhonghua Yan Ke Za Zhi; 2004 Mar; 40(3):160-4. PubMed ID: 15307985
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.